Physician profile
James E Odorisio
NPI 1598820219
$4,480.07
in general payments reported to CMS, 2019-2025
13 companies · $803 in 2025
The $803 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $670 · 2020: $674 · 2021: $669 · 2022: $548 · 2023: $628 · 2024: $487 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,918.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,937.49 | 2021-2025 | Venaseal, In.Pact Admiral |
| Smith+Nephew, INC. | $771.99 | 2019-2025 | Grafix Pl, Stravix, Collagenase Santyl |
| Musculoskeletal Transplant Foundation INC. | $712.54 | 2019-2021 | |
| Medtronic Vascular, INC. | $341.65 | 2019-2020 | |
| Organogenesis INC. | $264.40 | 2020-2025 | Puraply Wound Matrix, Apligraf, Affinity |
| Mimedx Group, INC. | $130.08 | 2024-2025 | |
| Integra Lifesciences Corporation | $76.82 | 2019 | |
| Solventum Corporation | $73.18 | 2025 | Activ.A.C. |
| Boston Scientific Corporation | $65.66 | 2020 | |
| Kerecis Limited | $52.53 | 2019 | |
| Walk Vascular, LLC | $20.00 | 2020 | |
| Kci USA, INC. | $18.48 | 2019 | |
| Mozarc Medical US LLC | $15.25 | 2024 | Chameleon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Odorisio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.